NX
Nexstim Plc
NXTMH.HE · HEL
9.26 € -1.70% (-0.16 €)
1M -9.96%
Market Cap 68.2M €
P/E Ratio 118.90x
Div. Yield -
ROE 11.75%
Bulios Fair Price
6.63 €
28.4% downside
Current Price
9.26 €
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NXTMH.HE is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
4 /100
Expensive P/E 118.90x
EV/EBITDA 40.89x
P/S 6.21x
Growth
25 /100
Declining EPS growth 30.66%
Rev. growth 4.81%
Book val. growth 0.92%
Profitability
30 /100
Weak Gross margin 35.19%
Net margin 5.23%
Op. margin 5.75%
Quality
49 /100
Average ROIC 7.06%
ROE 11.75%
ROA 4.35%
Debt
74 /100
Low Debt/Equity 0.99x
Current ratio 1.25x
Int. coverage 10.70x
Stability
29 /100
Unstable Beta 0.44x
Rev. volatility 27.25%
EPS volatility 182.83%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NXTMH.HE
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Mikko Karvinen
Employees
44
Headquarters
Helsinki
Upcoming events
01 MAR
Earnings
Upcoming earnings report